Selective COX-2 inhibitors--side effects in relation to non-specific non-steroidal anti-inflammatory drugs
Hansen, J.M.øl.; de Muckadell, O.B.S.
Ugeskrift for Laeger 166(50): 4581-4584
2004
ISSN/ISBN: 0041-5782 PMID: 15633545 Document Number: 572490
Document emailed within 1 workday
Related Documents
Hirata, S.; Kadowaki, D.; Narita, Y. 2016: Drug-induced kidney injury by non-steroidal anti-inflammatory drugs: do COX-2 selective inhibitors and acetaminophen induce kidney injury? Nihon Jinzo Gakkai Shi 58(7): 1059-1063Hirschelmann, R. 1992: Non-steroidal anti-inflammatory drugs--more than prostaglandin synthesis inhibitors! Medizinische Monatsschrift für Pharmazeuten 15(7): 194-195
Nishikawa, M.; Shirakawa, S.; Hidaka, H. 1987: Non-steroidal anti-inflammatory drugs. Suppression of biological response and non-steroidal anti-inflammatory drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 45(5): 1093-1101
Sherer, Y.; Bar-Dayan, Y.; Shoenfeld, Y. 1997: Selective inhibitors of cyclooxygenase-2 in upgrade in nonsteroidal anti-inflammatory drugs Harefuah 132(6): 411-416
Patrono, C. 2010: Cardiovascular effects of low-dose aspirin, traditional non-steroidal anti-inflammatory drugs and coxibs Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 165(1-2): 115-123; Discussion 124
Kaneo, Y.; Sento, C.; Kinoshita, R.; Kato, Y. 1981: Protein binding of non-steroidal anti-inflammatory drugs. V. Effects of various drugs on the binding of naproxen to bovine serum albumin Acta Pharmaceutica Suecica 18(1): 45-54
Catanese, B.; Picollo, R.; Corradino, C. 1986: Effects of benzydamine and other non-steroidal anti-inflammatory drugs on platelet aggregation induced by: arachidonic acid, ADP and collagen Bollettino Chimico Farmaceutico 125(7): 228-233
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Weissmann, G. 1979: Different effects of steroidal and non-steroidal anti-inflammatory agents on inflammation Reumatizam 26(6): 207-214
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Mizushima, Y. 1983: Pro-drugs of non-steroidal anti-inflammatory agents European Journal of Rheumatology and Inflammation 6(2): 141-142
Kuska, J. 1987: Nephrotoxicity of non-steroidal anti-inflammatory drugs Polski Tygodnik Lekarski 42(34): 1062-1064
Joshi, V.R.; Sainani, G.S. 1985: Non-steroidal anti-inflammatory drugs and kidney Journal of the Association of Physicians of India 33(10): 629-630
Paolinelli, E.; Piergiacomi, G. 1983: Non-steroidal anti-inflammatory drugs (NSAID): how many? which ones? La Clinica Terapeutica 104(2): 131-142
Kasemsarn, P.; Kulthanan, K.; Tuchinda, P.; Dhana, N.; Jongjarearnprasert, K. 2011: Cutaneous reactions to non-steroidal anti-inflammatory drugs Journal of Drugs in Dermatology: Jdd 10(10): 1160-1167
Colin, R. 1991: Digestive complications of non-steroidal anti-inflammatory drugs Schweizerische Medizinische Wochenschrift 121(20): 716-721
Alušík, Štefan.; Paluch, Zoltán. 2018: Cardiovascular risk of non-steroidal anti-inflammatory drugs Vnitrni Lekarstvi 64(3): 266-271
Davis, A.; Gilhooley, M.; Agius, M. 2010: Using non-steroidal anti-inflammatory drugs in the treatment of depression Psychiatria Danubina 22(Suppl 1): S49-S52
Van Berge Henegouwen, G.P.; Bijlsma, J.W. 1991: Therapeutic protocol in ulcers due to non-steroidal anti-inflammatory drugs Nederlands Tijdschrift Voor Geneeskunde 135(12): 504-508
Mitchell, H.; Barraclough, D.; Muirden, K.D. 1982: Blood-loss studies for new non-steroidal anti-inflammatory drugs Medical Journal of Australia 1(8): 328